Literature DB >> 25563560

Circulating tumor necrosis factor-α and YKL-40 level is associated with remission status following salvage therapy in relapsed non-Hodgkin lymphoma.

Tarec C El-Galaly1, Anders E Bilgrau1, Eva Gaarsdal2, Tobias W Klausen2, Lars M Pedersen2,3, Kaspar R Nielsen4, John Bæch4, Martin Bøgsted1,5,6, Karen Dybkær1,5,6, Julia S Johansen7, Hans E Johnsen1,2,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25563560     DOI： 10.3109/10428194.2014.1001984

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

1.  YKL-40 mediates airway remodeling in asthma via activating FAK and MAPK signaling pathway.

Authors:  Yu Sun; Zhaoquan Shi; Bing Liu; Xian'Gui Li; Ge Li; Feng Yang; Hao Tang
Journal:  Cell Cycle       Date:  2020-04-14       Impact factor: 4.534

2.  YKL-40 promotes the migration and invasion of prostate cancer cells by regulating epithelial mesenchymal transition.

Authors:  Hailong Hao; Lei Wang; Huiqing Chen; Liwu Xie; Tao Bai; Hongyu Liu; Dongwen Wang
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

3.  YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome.

Authors:  B Kornblit; T Wang; S J Lee; S R Spellman; X Zhu; K Fleischhauer; C Müller; M R Verneris; K Müller; J S Johansen; L Vindelov; P Garred
Journal:  Bone Marrow Transplant       Date:  2016-07-18       Impact factor: 5.483

4.  Inherited Inflammatory Response Genes Are Associated with B-Cell Non-Hodgkin's Lymphoma Risk and Survival.

Authors:  Kaspar René Nielsen; Rudi Steffensen; Mette Dahl Bendtsen; Maria Rodrigo-Domingo; John Baech; Thure Mors Haunstrup; Kim Steve Bergkvist; Alexander Schmitz; Julie Stoeveve Boedker; Preben Johansen; Karen Dybkaeær; Martin Boeøgsted; Hans Erik Johnsen
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.